Skip to content

Effects of EED on Zn Absorption and Retention in Children From a MNP

Effects of Environmental Enteric Dysfunction (EED) on Zinc (Zn) Absorption and Retention in Young Children: Study 2 - Absorption of Zn From a Multi-micronutrient Powder (MNP)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02758444
Acronym
ZEED2
Enrollment
80
Registered
2016-05-02
Start date
2015-11-30
Completion date
2019-02-28
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Environmental Enteric Dysfunction, Zinc Deficiency

Keywords

environmental enteric dysfunction, environmental enteropathy, zinc absorption, Bangladesh, toddlers, zinc isotope

Brief summary

The overall objective is to determine the impact of EED on total daily zinc absorption of young Bangladeshi children (18-24 months of age) in an austere setting with high rates of diarrhea, stunting, and micro-nutrient deficiencies..

Detailed description

Participating children are screened for EED using the lactulose:mannitol ratio test and assigned to one of two groups: +EED or -EED. After assignment to one of the two groups, proposed subjects will be randomized to one of four supplement groups: Micronutrient powder (MNP) with 15 mg Zn, MNP with 10 mg Zn, MNP with 5 mg Zn, and MNP with 0 mg Zn. Children will receive the supplement once with a meal on Day 8 of the study. Absorption of zinc from the supplement and from other non-supplemented meals will be determined using zinc stable isotope technology.

Interventions

DIETARY_SUPPLEMENTMicronutrient Powder (MNP) + 15 mg Zn

Children will have the supplement powder added to one meal on study day 1. Absorption of zinc from this meal will be measured using zinc stable isotope techniques.

DIETARY_SUPPLEMENTMNP without Zn

Same as above except MNP will not contain Zn

DIETARY_SUPPLEMENTMNP + 10 mg Zn

Same as above except MNP will contain 10 mg Zn

DIETARY_SUPPLEMENTMNP + 5 mg Zn

Same as above except MNP will contain 5 mg Zn

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh
CollaboratorOTHER
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Months to 24 Months
Healthy volunteers
Yes

Inclusion criteria

* Absence of apparent health problems that would impair ability to consume regular diet, to tolerate zinc supplements, or to comply with demands of metabolic studies * Length for age Z (LAZ) score between -1.5 to -3.0 * Hg ≥ 8

Exclusion criteria

* Outside age range * Hb \< 8 * Chronic illness * Zinc supplement within past 2 weeks (including for treatment of diarrhea or MNP containing zinc) * Severe stunting and/or severe acute malnutrition (SAM): LAZ \<-3; WHZ \<-3 or MUAC \< 115 or edema

Design outcomes

Primary

MeasureTime frameDescription
Total daily absorbed zinc (TAZ)1 dayMeasured during the meal to determine the effects of EED on zinc absorption.

Secondary

MeasureTime frameDescription
Serum retinol1 dayMeasured prior to the meal.
Methyl malonic acid1 dayMeasured prior to the meal.
Vitamin B121 dayMeasured prior to the meal.
Serum ferritin1 dayMeasured prior to the meal.
Soluble transferrin receptors1 dayMeasured prior to the meal.
CRP1 dayMeasured prior to the meal.
AGP1 dayMeasured prior to the meal.
Alkaline phosphatase1 dayMeasured prior to the meal.
Serum endocab1 dayMeasured prior to the meal.
Neopterin1 dayMeasured prior to the meal.
Myeloperoxidase1 dayMeasured prior to the meal.
Calprotectin1 dayMeasured prior to the meal.
alpha 1 antitrypsin1 dayMeasured prior to the meal.
Exchangeable zinc pool (EZP)1 daySize of exchangeable Zn pool (EZP) measured with zinc isotope methods prior to the meal.
Plasma zinc1 dayMeasured prior to the meal.
TNF alpha1 dayMeasured prior to the meal.

Countries

Bangladesh, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026